Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation

Blood

Volumn 87, Issue 9, 1996, Pages 3993-4000

  Albi, Nicola ^b   Ruggeri, Loredana ^b   Aversa, Franco ^b   Merigiola, Carla ^b   Tosti, Antonella ^b   Tognellini, Rita ^b   Grossi, Carlo E ^b   Martelli, Massimo F ^b   Velardi, Andrea ^a  

^a POLICLINICO MONTELUCE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA C ANTIGEN; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ACUTE LEUKEMIA; ALLELE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DAUDI CELL; HLA MATCHING; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANTIGENS, CD3; ANTIGENS, CD8; BONE MARROW TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA; RECEPTORS, IMMUNOLOGIC;

EID: 0029988391     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3993.bloodjournal8793993     Document Type: Article

References (41)

1. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewsky J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders JE, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 328:593, 1993
2. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765, 1985
3. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos BB, O'Quingley J, Romberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engrafment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
4. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B, Hodes MZ, Good RA, O'Reilly RJ: Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341, 1983
5. O'Reilly RJ, Collins NH, Kernan N, Brochstein J, Dinsmore R, Kirkpatrik D, Siena S, Keever C, Shank B, Wolf L, Dupont B, Reisner Y: Transplantation of marrow depleted of T cells by soybean lectin agglutination and E-rosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplant Proc 17:455, 1985
6. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, Jacucci R, Zei T, Martelli MP, Gambelunghe C, Rossetti M, Caputo P, Latini P, Aristei C, Raymondi C, Reisner Y, Martelli MF: Successful engrafment of T-cell-depleted haploidentical, "three loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 84:3948, 1994
7. Reisner Y, Martelli MF: Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 16:437, 1995
8. Ault KA, Antin JH, Ginsburg D, Orkin SH, Rappeport JM, Keohan ML, Martin P, Smith BR: Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 161:1483, 1985
9. Keever CA, Welte K, Small T, Levick J, Sullivan M, Hauch M, Evans RL, O'Reilly RJ: Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marow. Blood 70:1893, 1987
10. +) cell populations in the reconstitution phase after human bone marrow transplantation. Blood 71:1196, 1988
11. Velardi A, Varese P, Terenzi A, Dembech C, Grossi CE, Moretta L, Martelli MF, Grignani F, Mingari MC: Lymphokine production by T-cell clones after human bone marrow transplantation Blood 74:1665, 1989
12. Velardi A, Varese P, Pende D, Grossi CE, Dembech C, Albi N, Terenzi A, Moretta L, Martelli MF, Mingari MC: Cytolytic function of clonable T cells after human bone marrow transplantation. Blood 75:1364, 1990
13. Hauch M, Gazzola MV, Small T, Bordignon C, Barnett L, Cunningham I, Castro-Malaspina H, O'Reilly RJ, Keever CA: Antileukemia potential of interleukin 2-activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood 75:2250, 1990
14. + natural killer cells requires the expression of an autosomic recessive gene on target cells. J Exp Med 172:47, 1990
15. Ciccone E, Colonna M, Viale O, Pende D, Di Donato C, Reinharz D, Amoroso A, Jeannet M, Guardiola J, Moretta A, Spies T, Strominger JL, Moretta L: Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B. Proc Natl Acad Sci USA 87:9794, 1990
16. Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A, Moretta L: Evidence of a killer (NK) cell repertoire for (Allo) antigen recognition: Definition of five distinct NK-determined allospecificities in humans. J Exp Med 175:709, 1992
17. Ciccone E, Pende D, Viale O, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, Moretta L: Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 176:963, 1992
18. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, Viale O: Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 89:7983, 1992
19. Colonna M, Brooks EG, Falco M, Ferrara GB, Strominger JL: Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260:1121, 1993
20. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL: HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 90:1200, 1993
21. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL: Specificity of HLA class I recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 178:1321, 1993
22. Litwin V, Gumperz JE, Parham P, Phillips JH, Lanier LL: NKB1: An NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180:537, 1994
23. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Agugliaro R, Barbaresi M, Pende D, Ciccone E, Lopez-Botet M, Moretta L: Human NK cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 180:545, 1994
24. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M: NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180:1235, 1994
25. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P: The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181:1133, 1995
26. Vitale M, Sivori S, Pende D, Agugliaro R, Di Donato C, Amoroso A, Malnati M, Bottino C, Moretta L, Moretta A: Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 1996 (in press)
27. Pende D, Di Donato C, Moretta L: A putative NK receptor for HLA-A. IX International Congress of Immunology. San Francisco, CA, 1995, p 479
28. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A: Human natural killer cells: Origin, clonality, specificity, and receptors. Adv Immunol 55:341, 1994
29. Kärre K: Express yourself or die: Peptides, MHC molecules, and NK cells. Science 276.978, 1995
30. + natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 172:695, 1990
31. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules. J Exp Med 172:1589, 1990
32. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Agugliaro R, Barbaresi M, Ciccone E, Moretta L: P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178:597, 1993
33. + T lymphocytes. I: Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody J Immunol 144:3238, 1990
34. Christiansen FT, Witt CS, Ciccone E, Townend D, Pende D, Viale O, Abraham LJ, Dawkins RL, Moretta L: Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: Ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med 178:1033, 1993
35. Ciccone E, Pende D, Vitale M, Nanni L, Di Donato C, Bottino C, Morelli L, Viale O, Amoroso A, Moretta A, Moretta L: Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol 24:1003, 1994
36. Lanzavecchia A, Scheiddeger D: The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur J Immunol 17:105, 1987
37. Moretta A, Poggi A, Olive D, Bottino C, Fortis C, Pantaleo G, Moretta L. Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): Analysis of the functional relationship among different pathways of activation. Proc Natl Acad Sci USA 84:1654, 1987
38. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016, 1995
39. Ferrini S, Camiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L. T-cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol 24:2294, 1994
40. Phillips JH, Gumperz JE, Parham P, Lanier LL: Superantigen-dependent cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268:403, 1995
41. Mingari MC, Vitale C, Cambiaggi A, Schiavetti F, Melioli G, Ferrini S, Poggi A: Cytolytic T lymphocytes displaying natural killer (NK)-like activity: Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TcR-mediated target cell lysis or lymphokine production. Int Immunol 7:697, 1995